These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22988701)

  • 1. Early diagnosis improves survival in colorectal cancer.
    Keane MG; Johnson GJ
    Practitioner; 2012; 256(1753):15-8, 2. PubMed ID: 22988701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial risk of colorectal cancer in subjects attending an organised screening programme.
    Castiglione G; Visioli CB; Zappa M; Grazzini G; Mallardi B; Mantellini P
    Dig Liver Dis; 2012 Jan; 44(1):80-3. PubMed ID: 21925983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving detection of colorectal cancer.
    Orbell J; West NJ
    Practitioner; 2010 Oct; 254(1733):17-21, 2-3. PubMed ID: 21141248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
    Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
    J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the management of iron deficiency anaemia.
    Goddard AF; James MW; McIntyre AS; Scott BB;
    Gut; 2011 Oct; 60(10):1309-16. PubMed ID: 21561874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening and early diagnosis of colorectal cancer].
    Lepage C; Faivre J
    Rev Prat; 2010 Feb; 60(2):200-4. PubMed ID: 20225558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer.
    Vaughan-Shaw PG; Cutting J; Borley N; Brooklyn T; Wheeler JM
    Colorectal Dis; 2014 Jan; 16(1):40-7. PubMed ID: 24103034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population.
    Ahmed S; Leslie A; Thaha MA; Carey FA; Steele RJ
    Br J Surg; 2005 Apr; 92(4):478-81. PubMed ID: 15609377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The positive predictive value of guaiac faecal occult blood test in relation to the number of positive squares in two consecutive rounds of colorectal cancer screening.
    Manfredi S; Philip J; Campillo B; Piette C; Durand G; Riou F; Bretagne JF
    Eur J Cancer Prev; 2011 Jul; 20(4):277-82. PubMed ID: 21633201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost analysis of screening methodology for family members of colorectal cancer patients.
    Rozen P; Ron E
    Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of colorectal cancer in general practice patients presenting with rectal bleeding, change in bowel habit or anaemia.
    Lawrenson R; Logie J; Marks C
    Eur J Cancer Care (Engl); 2006 Jul; 15(3):267-71. PubMed ID: 16882123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of colorectal carcinoma. Pros and cons].
    von Betzler M
    MMW Fortschr Med; 2005 Apr; 147(14):26-8. PubMed ID: 15887679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does colorectal cancer present? Symptoms, duration, and clues to location.
    Majumdar SR; Fletcher RH; Evans AT
    Am J Gastroenterol; 1999 Oct; 94(10):3039-45. PubMed ID: 10520866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.